Oncofertility — an overview of modern methods of ovarian tissue cryopreservation

Rukhliada N.N.

Sankt-Peterburgskiĭ NII skoroĭ pomoshchi im. I.I. Dzhanelidze

SPIN RSCI: 4851-0283
Scopus AuthorID: 57191912761
ORCID: 0000-0002-3548-0468

Kazantsev V.A.

Federal State budgetary Educational Institution of Higher Education «St. Petersburg State Pediatric Medical University» of the Ministry of Healthcare of the Russian Federation, Litovskaya street, St. Petersburg, Russia, 2, 194100

Oncofertility — an overview of modern methods of ovarian tissue cryopreservation

Authors:

Rukhliada N.N., Kazantsev V.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2018;24(1): 53‑56

DOI: 10.17116/repro201824153-56

Downloaded: 79

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Rukhliada NN, Kazantsev VA. Oncofertility — an overview of modern methods of ovarian tissue cryopreservation. Russian Journal of Human Reproduction. 2018;24(1):53‑56. (In Russ.)
https://doi.org/10.17116/repro201824153-56

Close metadata

Recommended articles:

Profile of serum autoantibodies in women with premature ovarian insufficiency receiving complex treatment using new surgical technologies. Russian Journal of Human Reproduction. 2024;(2):32-41

Dynamics of the condition of patients with premature ovarian insufficiency and the autoantibody profile before and after the use of new surgical technologies in complex treatment. Russian Journal of Human Reproduction. 2024;(5):25-34

Reproductive aspects in the treatment of colorectal endometriosis. Russian Journal of Human Reproduction. 2024;(6):140-148

Gonadotropin-releasing hormone agonists as a chance for motherhood in the future. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):30-36

Predicting the risk of decreased ovarian reserve after surgical treatment of patients with deep infiltrative endometriosis using artificial intelligence. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):92-102

Despite the significant success in the treatment of cancer patients, the issue of fertility preservation in such cases remains unresolved. The development of universal certified method of ovarian tissue cryopreservation is needed. One of the possible methods for increasing the cryopreservation effectiveness can be the use of xenon clathrates in addition to conventional freezing.

Keywords:

ovarian tissue cryopreservation

vitrification

slow freezing

ovarian reserve

xenon clathrates

Authors:

Rukhliada N.N.

Sankt-Peterburgskiĭ NII skoroĭ pomoshchi im. I.I. Dzhanelidze

SPIN RSCI: 4851-0283
Scopus AuthorID: 57191912761
ORCID: 0000-0002-3548-0468

Kazantsev V.A.

List of references:

Skaznik-Wikiel ME, Gilbert SB, Meacham RB, Kondapalli LA. Fertility preservation options for men and women with cancer. Reviews in Urology. 2015;17(4):211-219.
The Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril. 2014;101(5):1237-1243.
Salama M, Woodruff TK. New advances in ovarian autotransplantation to restore fertility in cancer patients. Cancer metastasis reviews. 2015;34(4):807-822. https://doi.org/10.1007/s10555-015-9600-2
Rosendahl M, Andersen MT, Ralfkioer E, Kjelsden L, Andersen MK, Andersen CY. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril. 2010;94:2186-2190.
Greve T, Clasen-Linde E, Andersen MT, Andersen MK, Sorensen SD, Rosendahl M, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;123:4311-4316.
Courbiere B, Caquant L, Mazoyer C, Franck M, Lornage J, Salle B. Difficulties improving ovarian functional recovery by microvascular transplantation and whole ovary vitrification. Fertil Steril. 2009;91:2697-2670.
Bastings L, Liebenthron J, Westphal JR, Beerendonk CC, van der Ven H, Meinecke B, Montag M, Braat DD, Peek R. Efficacy of ovarian tissue cryopreservation in a major European center. Journal of Assisted Reproduction and Genetics. 2014;31(8):1003-1012.
Bastings L, Westphal JR, Beerendonk CCM, et al. Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency. Journal of Assisted Reproduction and Genetics. 2016;33(12):1605-1614. https://doi.org/10.1007/s10815-016-0816-z
Keros V, Xella S, Hultenby K, Pettersson K, Sheikhi M, Volpe A, et al. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod. 2009;24:1670-1683.
Silber S, Kagawa N, Kuwayama M, Gosden R. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010;94:2191-2196.
Isachenko V, Lapidus I, Isachenko E, Krivokharchenko A, Kreienberg R, Woriedh M, et al. Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation. Reprod (Cambridge). 2009;138(2):319-327. https://doi.org/10.1530/rep-09-0039
Rukhlyada NN, Motovilova NO, Gryaznov AYu. Prospects and the first results of ovarian tissue autotransplantation. Reproduction problems. 2013;2:48-51. (In Russ.)
Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000;342:1919.
Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Live birth after orthotopic transplantation of cryopreserved ovarian issue. Lancet. 2004;364:1405-1410.
Radford JA, Lieberman BA, Brison D, Smith AR, Critchlow JD, Russell SA, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet. 2001;357:1172-1175.
Miyazaki Y, Adachi T, Utsumi J, Shichino T, Segawa H. Xenon has greater inhibitory effects on spinal dorsal horn neurons than nitrous oxide in spinal cord transected cats. Anesth Analg. 1999;88:893-897.
Dovgusha VV. Discussion of the effects of indifferent gases on the organizm: Monograph. Saint-Petersburg. 2011;18-20. (In Russ.)
Rukhlyada NN, Berlev IV, Urmancheeva AD. Technologies for the fertility preservation for women’s with oncological diseases and after gonadotoxic therapy: a handbook for physicians. Saint-Petersburg 2014;27. (In Russ.)
Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol. 2005;58:182-193.
Ma D, Hossain M, Pettet GK, et al. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab. 2006;26:199-208.
Lobo N, Yang B, Rizvi M, et al. Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy? J Neurosci Res. 2013;91:473-478.
Roehl AB, Funcke S, Becker MM, et al. Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat. Anesthesiology. 2013;118:1385-1394.
Zhao H, Ning J, Savage S, Kang H, Lu K, Zheng X, George AJ, Ma D. A novel strategy for preserving renal grafts in an ex vivo setting: potential for enhancing the marginal donor pool. FASEB J. 2013;27:4822-4833.
Spaggiari S, Kepp O, Rello‐Varona S, Chaba K, Adjemian S, Pype J, Galluzzi L, Lemaire M, Kroemer G. Antiapoptotic activity of argon and xenon. Cell Cycle. 2013;12:2636-2642.
Scherbakov VI, Tel’pukhov AV, Khokhlov AV. Obratimaya glubokaya gipotamiya tselostnogo organizma krys. Bull Eksp Biol i Med. 1989;107:5:543-545. (In Russ.)
Sheleg S, Hixon H, Cohen B, Lowry D, Nedzved M. Cardiac mitochondrial membrane stability after deep hypothermia using a xenon clathrate cryostasis protocol — an electron microscopy study. Int J Clin Exp Pathol. 2008;1:440-447.

Close metadata